Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Extraction: Advanced Methods

Extraction: Advanced Methods

Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is formed in...

Complexation Equilibria: The Chelate Effect

Complexation Equilibria: The Chelate Effect

In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...

Metal-Ligand Bonds

Metal-Ligand Bonds

The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Drugs that Destabilize Microtubules

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Glyco-Conjugation of Thiosemicarbazone Copper(II) Complexes Enhances Selectivity toward Cancer Cells Overexpressing GLUT1.

ACS omega·2026

Same author

Synthesis, Structural Insights, and In Vitro Evaluation of Novel Silver Complexes Supported by Amantadine-Functionalized Bis(pyrazolyl)acetate Ligands as Anticancer Agents.

ACS omega·2026

Same author

Structural and Biological Insights Into Copper(I) Phosphane Complexes With Boron-Phenylated Poly(3-(CF<sub>3</sub>)Pyrazolyl)- and Poly(6-(CF<sub>3</sub>)-2-pyridyl)-Borates.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026

Same author

Synthesis, Structural Studies, and Biological Evaluation of Copper(I) and Copper(II) Complexes Supported by Bis(pyrazol-1-yl)acetate Ligand Functionalized with Amantadine for the Treatment of Glioblastoma.

International journal of molecular sciences·2026

Same author

Conjugation of Functionalized Gold Nanorods and Copper (I)-Based Drug: An Anisotropic Nano Drug Delivery System.

Nanomaterials (Basel, Switzerland)·2026

Same author

Unravelling a clinical role of peripheral blood leukemia stem cells at diagnosis in chronic myeloid leukemia patients: Final results of prospective FLOWERS study.

Cancer·2025

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Copper complexes as anticancer agents.

Cristina Marzano¹, Maura Pellei, Francesco Tisato

¹Dipartimento di Scienze Farmaceutiche, Università di Padova, Padova, Italy. cristina.marzano@unipd.it

Anti-Cancer Agents in Medicinal Chemistry

|February 10, 2009

Summary

Copper complexes show promise as less toxic antitumor drugs, offering an alternative to platinum-based chemotherapy. Research focuses on understanding copper compound structures and their anticancer activity to improve drug development.

More Related Videos

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Related Experiment Videos

Last Updated: Jun 25, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Area of Science:

Medicinal Chemistry
Inorganic Chemistry
Pharmacology

Background:

Metal-based drugs, like cisplatin, are vital in chemotherapy but face limitations due to toxicity and resistance.
Developing novel metallodrugs, particularly those not based on platinum, is crucial for enhanced efficacy and reduced side effects.
Copper complexes are emerging as attractive candidates for anticancer agents, leveraging the potential for lower endogenous toxicity.

Purpose of the Study:

To review recent advancements in the design and development of copper(I, II) complexes as antitumor agents.
To highlight structure-activity relationships within various copper(I, II) complex classes.
To address the scarcity of comprehensive surveys and mechanistic insights into copper-based anticancer compounds.

Main Methods:

Literature review of copper(I, II) complexes synthesized and evaluated for antitumor activity in the last decade.
Analysis of structure-activity relationships based on ligand and donor atom variations.
Compilation of data on the molecular mechanisms underlying the observed antitumor effects.

Main Results:

Copper(I, II) complexes exhibit significant potential as anticancer agents, with properties tunable by ligand design.
Structure-activity relationship studies are key to optimizing copper complexes for improved antitumor efficacy.
A growing body of research indicates diverse mechanisms of action for these compounds.

Conclusions:

Copper complexes represent a promising avenue for developing next-generation anticancer therapies with potentially reduced toxicity.
Further research into the molecular mechanisms of copper-based drugs is essential for their successful clinical translation.
This review provides a valuable resource for researchers in the field of metallodrug development.